Amarin | L'Utile Ante Imposte

Prezzo Delle Azioni
15.51
Cambio Giornaliero
-0.09 -0.55%
Mensile
-0.29%
Annuale
34.83%
Q1 Previsione
15.11




L'Utile Ante Imposte Cambiamento Data
AbbVie USD 4.38B 1.92B 2025-09
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
Amarin USD -8.12M 5.34M 2025-09
AstraZeneca USD 3.24B 117M 2025-09
BioCryst Pharmaceuticals USD -86.95M 73.5M 2024-12
DBV Technologies USD -33.16M 8.6M 2025-09
Esperion Therapeutics USD 67.66M 3.6M 2024-09
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Halozyme Therapeutics USD 218.96M 14.02M 2025-09
Heron Therapeutics USD -4.85M 4.39M 2024-09
Ionis Pharmaceuticals USD -129M 253M 2025-09
Nektar Therapeutics USD -37.05M 15.27M 2024-09
Neurocrine Biosciences USD 239.4M 52.4M 2025-12
Novartis USD 4.2B 335M 2025-09


Amarin L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.